{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:12:53Z","timestamp":1753438373655},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.clinthera.2014.09.022","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T02:51:05Z","timestamp":1414032665000},"page":"439-447","source":"Crossref","is-referenced-by-count":1,"title":["Tolerability and Pharmacokinetics of Two Formulations of Megestrol Acetate under Fed Conditions in Healthy Volunteers"],"prefix":"10.1016","volume":"37","clinical-trial-number":[{"clinical-trial-number":"nct01342055","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yo Han","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Youn","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seokjoon","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yook-Hwan","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong-Seok","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keunsu","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hack","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyun-Seop","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.09.022_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0305-7372(89)90004-2","article-title":"Megestrol acetate: clinical experience","volume":"16","author":"Schacter","year":"1989","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clinthera.2014.09.022_bib2","first-page":"35","article-title":"Treatment of anorexia and weight loss with megestrol acetate in patients with cancer or acquired immunodeficiency syndrome","volume":"18","author":"Tchekmedyian","year":"1991","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clinthera.2014.09.022_bib3","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/82.13.1127","article-title":"Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia","volume":"82","author":"Loprinzi","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clinthera.2014.09.022_bib4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/bmj.315.7117.1219","article-title":"ABC of palliative care. Anorexia, cachexia, and nutrition","volume":"315","author":"Bruera","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2014.09.022_bib5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"Tisdale","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clinthera.2014.09.022_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0749-0690(18)30146-0","article-title":"Involuntary weight loss in elderly outpatients: recognition, etiologies, and treatment","volume":"13","author":"Wallace","year":"1997","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.clinthera.2014.09.022_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0169-5002(03)00077-1","article-title":"A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer","volume":"40","author":"Scott","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clinthera.2014.09.022_bib8","first-page":"3661","article-title":"The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy","volume":"22","author":"Persson","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clinthera.2014.09.022_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1532-5415.2000.tb04993.x","article-title":"Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study","volume":"48","author":"Yeh","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2014.09.022_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02592554","article-title":"Megestrol acetate in neoplastic anorexia\/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy","volume":"25","author":"Mantovani","year":"1995","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.clinthera.2014.09.022_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/bjc.1990.310","article-title":"Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice","volume":"62","author":"Beck","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clinthera.2014.09.022_bib12","unstructured":"Par Pharmaceutical Companies, Inc., Megace ES drug information, 2007. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/021778s002s003lbl.pdf. Accessed December 12, 2013."},{"key":"10.1016\/j.clinthera.2014.09.022_bib13","first-page":"185","article-title":"Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension","volume":"4","author":"Deschamps","year":"2009","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.clinthera.2014.09.022_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jamda.2007.05.001","article-title":"Pharmacological treatment of geriatric cachexia: evidence and safety in perspective","volume":"8","author":"Yeh","year":"2007","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.clinthera.2014.09.022_bib15","unstructured":"Korea Food and Drug Administration (KFDA). Guideline for the Validation of Bioanalytical Method, 2010 [in Korean]. http:\/\/drug.kfda.go.kr\/Data\/KO_DU\/20100804092704_0.hwp. Accessed April 26, 2012."},{"key":"10.1016\/j.clinthera.2014.09.022_bib16","unstructured":"Food Effect Working Group of the Biopharmaceutics Coordinating Committee, Office of Pharmaceutical Science. Guidance for industry: food-effect bioavailability and fed bioequivalence studies, 2002. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm064964.htm. Accessed April 26, 2012."},{"key":"10.1016\/j.clinthera.2014.09.022_bib17","series-title":"Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications","first-page":"161","author":"Gabrielsson","year":"2006"},{"key":"10.1016\/j.clinthera.2014.09.022_bib18","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1378\/chest.126.6.1855","article-title":"Simplified detection of dynamic hyperinflation","volume":"126","author":"Gelb","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2014.09.022_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jchromb.2005.01.028","article-title":"Development of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of flurogestone acetate in ovine plasma","volume":"819","author":"Monnoyer","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.clinthera.2014.09.022_bib20","first-page":"295","article-title":"Nanocrystal technology, drug delivery and clinical applications","volume":"3","author":"Junghanns","year":"2008","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.clinthera.2014.09.022_bib21","series-title":"Seoul","first-page":"5","article-title":"Investigator\u2019s brochure","author":"Apetrol","year":"2011"},{"key":"10.1016\/j.clinthera.2014.09.022_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future","volume":"47","author":"Muller","year":"2001","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814006146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814006146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T14:42:34Z","timestamp":1565966554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814006146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0149291814006146"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.09.022","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}